Bottom Line: A cost-effectiveness study used a hypothetical group of women in the United Kingdom to compare risk-based breast cancer screening programs with a standard age-based screening program and no screening. Analysis was done from the perspective of the National Health Service.
Authors: Nora Pashayan, M.D., Ph.D., of University College London, England, and coauthors
Related Material: A podcast and editorial, "Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine," by Megan C. Roberts, Ph.D., of the National Cancer Institute, Rockville, Maryland, also are available on the For The Media website .
To Learn More: The full study is available on the For The Media website .
( doi:10.1001/jamaoncol.2018.1901)
Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
JAMA Oncology